©The Author(s) 1997.
World J Gastroenterol. Dec 15, 1997; 3(4): 253-254
Published online Dec 15, 1997. doi: 10.3748/wjg.v3.i4.253
Published online Dec 15, 1997. doi: 10.3748/wjg.v3.i4.253
Table 2 Evaluational indexes for CA19-9-based diagnosis of gastrointestinal benign and malignant diseases
| Disease | n | Positive | Se, % | Sp, % | Ac, % | +PV, % | -PV, % |
| Gastric cancer | |||||||
| Preoperation and recurrence | 55 | 26 | 47.3 | 100.0 | 65.9 | 100.0 | 50.8 |
| Colorectal cancer | |||||||
| Preoperation and recurrence | 66 | 33 | 50.0 | 100.0 | 65.6 | 100.0 | 47.6 |
| Esophageal cancer | 10 | 2 | 20.0 | 100.0 | 80.0 | 100.0 | 78.9 |
| Pancreatic cancer | 7 | 6 | 83.3 | 100.0 | 97.3 | 100.0 | 96.8 |
| GI benign disorders | 30 | 0 | 0.0 | 100.0 | 78.7 | 787 |
- Citation: Zhao JZ, Wu BH. Clinical significance of CA19-9 in diagnosis of digestive tract tumors. World J Gastroenterol 1997; 3(4): 253-254
- URL: https://www.wjgnet.com/1007-9327/full/v3/i4/253.htm
- DOI: https://dx.doi.org/10.3748/wjg.v3.i4.253